Post-pandemic Era-Global Nuclear Medicine & Radio Pharmaceuticals Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 256006 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Nuclear Medicine & Radio Pharmaceuticals Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 SPECT Radiopharmaceuticals -Product Introduction and Major Manufacturers
      1.1.2 PET Radiopharmaceuticals -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.1.1 China Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.1.2 China Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.2.1 EU Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.2.2 EU Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.3.1 USA Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.3.2 USA Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.4.1 Japan Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.5.1 India Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.5.2 India Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.7.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.7.2 South America Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2015-2026)
      2.8.1  Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (2015-2026)
      2.8.2  Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Nuclear Medicine & Radio Pharmaceuticals Market Assessment by Segment
    3.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity and Growth Rate
    3.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Type
    3.3 Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue by Type
    3.4 Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Application
4 Global Nuclear Medicine & Radio Pharmaceuticals Market Assessment by Regions
    4.1 Global Nuclear Medicine & Radio Pharmaceuticals Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Nuclear Medicine & Radio Pharmaceuticals Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Nuclear Medicine & Radio Pharmaceuticals Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Nuclear Medicine & Radio Pharmaceuticals Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue Market Share of Manufacturers (2019-2020)

7 Nuclear Medicine & Radio Pharmaceuticals Competitive Analysis
     7.1 GE Healthcare
        7.1.1 GE Healthcare Company Profiles
        7.1.2 GE Healthcare Product Introduction
        7.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 Philips Healthcare
        7.2.1 Philips Healthcare Company Profiles
        7.2.2 Philips Healthcare Product Introduction
        7.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Siemens Healthcare
        7.3.1 Siemens Healthcare Company Profiles
        7.3.2 Siemens Healthcare Product Introduction
        7.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Toshiba
        7.4.1 Toshiba Company Profiles
        7.4.2 Toshiba Product Introduction
        7.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 Hitachi
        7.5.1 Hitachi Company Profiles
        7.5.2 Hitachi Product Introduction
        7.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Carestream
        7.6.1 Carestream Company Profiles
        7.6.2 Carestream Product Introduction
        7.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Esaote
        7.7.1 Esaote Company Profiles
        7.7.2 Esaote Product Introduction
        7.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 Shimadzu
        7.8.1 Shimadzu Company Profiles
        7.8.2 Shimadzu Product Introduction
        7.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
     7.9 TriFoil Imaging
        7.9.1 TriFoil Imaging Company Profiles
        7.9.2 TriFoil Imaging Product Introduction
        7.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.9.4 SWOT Analysis
     7.10 Biosensors International Group, Ltd
        7.10.1 Biosensors International Group, Ltd Company Profiles
        7.10.2 Biosensors International Group, Ltd Product Introduction
        7.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production, Revenue (2015-2020)
        7.10.4 SWOT Analysis
8 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit) by Type (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (%) by Type (2019 -2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Value (Million USD) by Type (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Value Market Share (%) by Type (2019-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit) by Application (2015-2026)
    Figure China Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales (Unit) by Type (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (Unit) by Application (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Unite) by Regions (2015-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Regions (2019-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Unite) by Regions (2015-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Regions (2019-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Nuclear Medicine & Radio Pharmaceuticals
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Nuclear Medicine & Radio Pharmaceuticals
    Figure Cost Structure of Nuclear Medicine & Radio Pharmaceuticals in 2020
    Table Global Nuclear Medicine & Radio Pharmaceuticals Capacity Share of Manufacturers (2019-2020)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Capacity Share of Manufacturers (2019-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share of Manufacturers (2019-2020)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share of Manufacturers (2019-2020)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table GE Healthcare Profiles
    Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure GE Healthcare SWOT Analysis
    Table Philips Healthcare Profiles
    Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Philips Healthcare SWOT Analysis
    Table Siemens Healthcare Profiles
    Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Siemens Healthcare SWOT Analysis
    Table Toshiba Profiles
    Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Toshiba SWOT Analysis
    Table Hitachi Profiles
    Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Hitachi SWOT Analysis
    Table Carestream Profiles
    Table Carestream Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Carestream Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Carestream SWOT Analysis
    Table Esaote Profiles
    Table Esaote Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Esaote Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Esaote SWOT Analysis
    Table Shimadzu Profiles
    Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Shimadzu SWOT Analysis
    Table TriFoil Imaging Profiles
    Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure TriFoil Imaging SWOT Analysis
    Table Biosensors International Group, Ltd Profiles
    Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Product Introduction
    Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Biosensors International Group, Ltd SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Nuclear Medicine & Radio Pharmaceuticals Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Nuclear Medicine & Radio Pharmaceuticals Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Nuclear Medicine & Radio Pharmaceuticals Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports